Silberstein, Stephen D. http://orcid.org/0000-0001-9467-5567
Cohen, Joshua M.
Yang, Ronghua
Gandhi, Sanjay K.
Du, Evelyn
Jann, Adelene E.
Marmura, Michael J.
Funding for this research was provided by:
Teva Pharmaceutical Industries, Petach Tikva, Israel.
Article History
Received: 6 October 2020
Accepted: 12 December 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: The study protocols were reviewed and approved by the appropriate institutional review board for each site. The clinical trials were conducted in accordance with Good Clinical Practice and the Declaration of Helsinki guidelines. Participants provided written informed consent prior to study initiation.
: All authors gave their consent for publication.
: Stephen D. Silberstein provides consultation to Alder, Allergan, Amgen, Autonomic Technologies, Avanir, Curelator Inc., Depomed, Dr. Reddy’s Laboratories, Ensured Inc., electroCore Medical LLC, eNeura Therapeutics, Insys Therapeutics, Lilly USA LLC, Supernus Pharmaceuticals, Teva Pharmaceuticals, Theranica, and Trigemina Inc. Adelene E. Jann has served on speakers bureaus for Allergan and Lundbeck. Michael J. Marmura has been a principal investigator for Allergan, gammaCore, Teva Pharmaceuticals, and Theranica; served on advisory boards/speakers bureaus for Alder, Amgen/Novartis, Antares Pharma, Eli Lilly and Company, Promius, Supernus Pharmaceuticals, and Valeant. Joshua M. Cohen, Ronghua Yang, Sanjay K. Gandhi, and Evelyn Du are employees of Teva Pharmaceuticals.